What are the terms under which a biotech company could be interested in having such an organisation as investor?

[HansjoergFromBEF]

What are possible conditions to arrange a loan or to invest in a company?

Is it reasonable to assume, that small biotech companies really could consider such an offer? A possible problem I see, it is not just about the money. It's also about the network an investor has, or if it is a major player in the pharma industry who invests, it's also about production facilities and distribution channels?

What would we have to offer?

[mhorisberger]

imho, this is hard to discuss without inside knowledge about the industry.
A way forward could be to collect data about companies and experimental therapies.
Based on this data, there would have to be direct communications with those companies to learn about their needs.

Not sure if there is a list already, I would imagine something like this:

Name	Country	Product
Opexa Therapeutics	US	Tcelna
AB Science	France	Masitinib
Ankar Pharmaceuticals	Spain / Philipines	AP-1
Alkremes Inc.		ALKS 8700
Arena Pharmaceutical		APD334
Antisense Therapeutics		ATL1102
Bionure	US	BN201
Concert Pharmaceutical		CTP-354
Glialogix	US	GLX1112
MediciNova		Ibudilast (MN-166)
Inhibikase	US	IkT-001Pro
Innate Immunotherapeutics Limited	Australia/New Zealand	MIS416
Roche	Switzerland	Ocrelizumab
Roche	Switzerland	Zenapax (Daclizumab)
Biogen	US	anti-LINGO-1
MedDaySAS	France	MD1003
ImStem Biotechnology		IMS001/IMS002

Obviously, talking to Roche or Biogen would not make sense, because they have more money than they can ever use?

Also, we would need a team member that has a medical background and can help to evaluate those experimental therapies for us.
I currently don't know anybody who could contribute that skill. Asking through some students or some familiy doctors could help...

Cheers, Markus